Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective
Title:
Cost effectiveness analysis of fesoterodine compared to mirabegron in first-line therapy setting for overactive bladder with urge urinary incontinence, from the Spanish National Health System perspective
Author:
Angulo, J.C. Sánchez-Ballester, F. Peral, C. Rejas, J. Ramos, J. Snedecor, S.J. Sudharshan, L. Liu, S. Luo, X.